Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

Weighted average

number of shares

outstanding: 13,235,755 13,235,755

Table 5

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the

Statement of Operations Information for Year Ended December 31, 2006

(Unaudited)

(In thousands, except share and per share amounts)

Change

in Fair

Value of Preferred

Non- Warrant Stock Deemed Stock GAAP as

GAAP Liability Accretion Dividend Compensation Reported

Income Statement

Classifications:

Research and

development $(31,924) $- $- $- $(1,706) $(33,630)

General and

administrative (10,733) (1,544) (12,277)

Depreciation and

amortization (952) (952)

Interest income 1,990 1,990

Interest expense (273) (273)

Change in fair

value of warrant

liability - (23) (23)

Other expense (1,180) (1,180)

Preferred stock

accretion - (159) (159)

Deemed dividend - (19,424) (19,424)

Summary:

Net loss: $(43,072) $(23) $(159) $(19,424) $(3,250) $(65,928)

Net loss per

share - basic

and diluted: $(58.52) $(0.03) $(0.22) $(26.39) $(4.42) $(89.58)

Weighted average

number of shares

outstanding: 735,967 735,967 '/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... GERMANTOWN, Md. , Aug. 3, 2015   ... it will release first half and second quarter 2015 ... 10 th , 2015.  The Company will host a ... results and provide a general business update. ... (Domestic US) and 1-412-902-4262 (International), and asking to join ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... analysis and premium industry insights on the global resorcinol industry. The report highlights ... study of vivid market scenarios and analysis of primary and secondary inputs from ...
(Date:7/30/2015)... 2015   GenoSpace , a leading provider ... analysis of genomic and other biomedical data, today ... the company as Vice President of Sales and ... "GenoSpace partners with its customers ... and explore complex sets of genomic, phenotypic and ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... known as the Beijing Genomics Institute), the largest genomics ... Chinese Academy of Sciences, together published the whole sequence ... in Genome Biology on July 6th, 2011 ... evolutionary and biomedical research. Rhesus macaque, also called ...
... of 193 different types of steel. The steel for each ... It is important, for example, that all parts are as ... parts of the car have to be super strong in ... strong nanostructured metals are now entering the scene, aimed at ...
... (Nasdaq: VPHM ) second quarter financial results for ... 2011 before the open of the U.S. financial markets. ... audio webcast at 9:00 a.m. Eastern Time on the same ... 2011 second quarter financial results and other business. ...
Cached Biology Technology:Whole sequence variation map reveals insight into evolutionary studies of rhesus macaque 2A new discovery paves the way for using super strong nanostructured metals in cars 2A new discovery paves the way for using super strong nanostructured metals in cars 3ViroPharma to Release 2011 Second Quarter Financial Results on July 28, 2011 2
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/30/2015)... -- To bolster its efforts and commitment to fighting cyber ... addition of two new team members. ... David Raviv will act as head of strategic alliances. ... providing the most secure solutions for the enterprise market. ... Technologies, a provider of security and management products, which was ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... (BRONX, NY) Scientists at Albert Einstein College ... new drug-delivery system with a powerful antimicrobial agent to ... study is published this month in the online version ... Staphylococcus aureus bacteria cause the majority of ...
... Russell A. Mittermeier, the president of Conservation International and ... Roger Tory Peterson Medal from the Harvard Museum of ... and conservation strategist who has written more than 500 ... 19 books. He has described 11 species new to ...
... Calif.) Scientists at UC Santa Barbara have made a ... function. They explain nature,s way of controlling whether these ... an ear, a liver, or any other part of the ... issue of the journal Cell . The scientists ...
Cached Biology News:New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
... Desselberger (1995) • This book is ... classical and molecular techniques currently used ... and analysis of virus-specific antibodies and ... presented covering immunoassays, blotting and hybridization ...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Bovine Serum...
Biology Products: